V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220017878 | 220008986 | 1.84 | 76.4 | null | 2014-06-13 | 2015-04-11 | IDARUBICIN | N | N | 220033863 | IDARUBICIN |
| 220017879 | 220008988 | 1.72 | 50.3 | Curative (C) | 2014-07-05 | 2014-07-06 | Oxaliplatin + Modified de Gramont | N | Y | 220033871 | CLOFARABINE + CYTARABINE |
| 220017880 | 220008991 | 1.78 | 75 | Adjuvant (A) | null | 2014-12-10 | Mitoxantrone | 02 | N | 220033893 | MITOXANTRONE |
| 220017881 | 220008993 | 1.57 | 51.9 | null | 2015-07-20 | 2015-07-29 | Cisplatin + Gemcitabine (D 1 & 8) | null | N | 220033898 | UKALL2014 |
| 220017883 | 220009000 | 1.64 | 63.9 | Curative (C) | 2013-09-12 | 2013-09-13 | Arsenic Triox + Tretinoin Ind W5-8 | 02 | N | 220033931 | ARSENIC TRIOXIDE + TRETINOIN |
| 220017884 | 220018091 | 1.52 | null | Curative (C) | 2017-09-10 | 2018-01-05 | Arsenic trioxide + Tretinoin | N | N | 220033933 | ARSENIC TRIOXIDE + TRETINOIN |
| 220017885 | 220018091 | 1.65 | 100.45 | Curative (C) | 2015-03-05 | 2015-03-05 | Alemtuzumab cond (RI ALLO CAMP100) | 2 | N | 220033933 | ALEMTUZUMAB |
| 220017886 | 220009003 | 1.79 | 86 | Curative (C) | 2015-02-26 | 2015-05-02 | PACLITAXEL | N | N | 220033943 | PACLITAXEL |
| 220017887 | 220009004 | 1.69 | null | null | null | 2014-04-03 | METHOTREXATE | N | N | 220033943 | FLUDARABINE + MELPHALAN |
| 220017888 | 220014811 | 1.71 | 74 | Palliative (P) | 2013-09-08 | 2013-09-15 | CISPLATIN + GEMCITABINE | 2 | N | 220033957 | OXALIPLATIN + MDG |
| 220017889 | 220014812 | 1.77 | 85.2 | Palliative (P) | 2014-05-20 | 2014-07-29 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 220033963 | PACLITAXEL |
| 220017890 | 220009010 | 1.94 | 70.5 | Disease modification (D) | 2016-02-09 | 2016-03-07 | Fludarabine + Melphalan RIC Allo | 02 | N | 220033965 | UKALL2014 |
| 220017891 | 220009015 | 1.76 | 84.5 | Palliative (P) | 2014-12-26 | 2014-12-26 | Alemtuzumab cond (RI ALLO CAMP100) | N | N | 220033983 | ALEMTUZUMAB |
| 220017892 | 220014815 | 1.65 | 48 | Palliative (P) | null | 2016-06-20 | Fludarabine + Melphalan RIC Allo | N | N | 220033984 | FLUDARABINE + MELPHALAN |
| 220017893 | 220009019 | null | 66.2 | Palliative (P) | null | 2013-11-05 | Fludarabine + Melphalan RIC Allo | N | N | 220033988 | ECX |
| 220017894 | 220014817 | 1.69 | 100.5 | Palliative (P) | 2017-12-20 | 2017-12-21 | CARBOPLATIN + GEMCITABINE | N | N | 220033993 | CLOFARABINE + CYTARABINE |
| 220017895 | 220009026 | 1.71 | null | Palliative (P) | 2018-04-10 | 2018-06-05 | Paclitaxel 80mg/m2 day 1 8 15 | 2 | N | 220033997 | PACLITAXEL |
| 220017896 | 220009028 | 1.8 | 88 | Palliative (P) | 2017-06-07 | 2017-06-21 | Carboplatin + Paclitaxel (3 weekly) | null | null | 220034002 | CARBOPLATIN + PACLITAXEL |
| 220017897 | 220009029 | 1.71 | 64 | Palliative (P) | 2018-05-12 | 2018-06-17 | CARBOPLATIN + ETOPOSIDE | 02 | N | 220034010 | CARBOPLATIN + ETOPOSIDE |
| 220017898 | 220009030 | 1.6 | 66 | Palliative (P) | 2013-09-26 | 2013-11-17 | ALEMTUZUMAB + BUSULFAN + FLUDARABINE | Y | N | 220034012 | CLOFARABINE + CYTARABINE |
| 220017899 | 220009030 | 1.75 | 80 | Curative (C) | null | 2017-01-24 | CARBOPLATIN + ETOPOSIDE | N | N | 220034012 | CARBOPLATIN + ETOPOSIDE |
| 220017900 | 220009031 | 1.62 | 89.8 | Palliative (P) | 2016-10-27 | 2016-11-01 | Mitox + Tretinoin Spanish Course 3 | 2 | N | 220034022 | MITOXANTRONE |
| 220017901 | 220014824 | 1.5 | 87 | null | 2016-06-29 | 2016-06-29 | Fludarabine + Melphalan RIC Allo | N | N | 220034035 | UKALL2014 |
| 220017902 | 220009036 | 1.61 | 43 | Curative (C) | 2016-08-24 | 2018-02-15 | FLUOROURACIL + IRINOTECAN | N | N | 220034036 | FLUDARABINE + MELPHALAN |
| 220017903 | 220018098 | 1.79 | 84.5 | Palliative (P) | 2018-04-26 | 2018-04-26 | UKALL 14 TRIAL | N | N | 220034038 | FBC |
| 220017904 | 220009040 | 1.82 | 95 | Curative (C) | null | 2015-04-06 | FLUOROURACIL + OXALIPLATIN | N | null | 220034055 | FBC |
| 220017905 | 220014826 | 1.78 | 96.4 | Curative (C) | 2017-06-10 | 2017-06-10 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | 220034064 | PACLITAXEL |
| 220017906 | 220009045 | 1.72 | null | Palliative (P) | 2014-08-25 | 2014-11-25 | FLUDARABINE + MELPHALAN | N | N | 220034070 | PONATINIB |
| 220017907 | 220009047 | 1.75 | 53.8 | Curative (C) | 2014-06-30 | 2014-08-28 | GEMTUZUMAB OZOGAMICIN | N | null | 220034076 | ECX |
| 220017908 | 220009048 | 1.87 | 75.6 | Curative (C) | 2015-04-20 | 2015-04-20 | METHOTREXATE | N | N | 220034076 | IRINOTECAN + MDG |
| 220017909 | 220009052 | 1.58 | 87 | Palliative (P) | 2014-01-16 | 2014-01-16 | Oxaliplatin + Modified de Gramont | 2 | null | 220034081 | GEMCARBO |
| 220017911 | 220019937 | 1.78 | 58.4 | Palliative (P) | 2013-11-10 | 2013-12-29 | Cytarabine intrathecal | N | N | 220034091 | CYTARABINE INTRATHECAL |
| 220017912 | 220009058 | 1.94 | 76.3 | Palliative (P) | 2016-06-23 | 2016-07-24 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | 220034101 | PACLITAXEL |
| 220017913 | 220014834 | 1.86 | 81.4 | null | 2016-07-17 | 2016-07-21 | Fludarabine + Melphalan RIC Allo | N | N | 220034109 | UKALL2014 |
| 220017914 | 220009061 | 1.7 | 109.6 | Not known (9) | 2016-07-30 | 2016-11-03 | ECX | N | N | 220034115 | DOCETAXEL |
| 220017915 | 220009065 | 1.51 | 60.9 | Disease modification (D) | 2013-08-28 | 2013-08-29 | FLUOROURACIL + OXALIPLATIN | N | N | 220034117 | METHOTREXATE |
| 220017916 | 220014837 | 1.69 | 80.6 | Curative (C) | 2018-05-21 | 2018-05-24 | Carboplatin + Paclitaxel (3 weekly) | null | null | 220034127 | CARBOPLATIN + PACLITAXEL |
| 220017917 | 220009072 | 1.69 | 61.85 | Curative (C) | 2017-02-23 | 2017-03-08 | Carboplatin + Paclitaxel (3 weekly) | N | N | 220034129 | CARBOPLATIN + PACLITAXEL |
| 220017918 | 220009072 | 1.69 | 77 | Curative (C) | 2017-12-14 | 2017-12-14 | Clofarabine + Cytarabine | 02 | N | 220034129 | CISPLATIN + GEMCITABINE |
| 220017919 | 220009076 | 1.69 | null | Curative (C) | 2014-04-23 | 2014-05-01 | Methotrexate + Folinic acid | N | null | 220034143 | GEMTUZUMAB OZOGAMICIN |
| 220017920 | 220014840 | 1.69 | 57 | Palliative (P) | 2014-02-10 | 2014-12-03 | PONATINIB | N | N | 220034155 | CISPLATIN + GEMCITABINE |
| 220017921 | 220009079 | 1.81 | 99.2 | Curative (C) | 2016-08-12 | 2016-09-24 | Carboplatin + Etoposide IV 3 day | N | N | 220034156 | CARBOPLATIN + ETOPOSIDE |
| 220017922 | 220009081 | 1.57 | 69 | Palliative (P) | 2018-05-15 | 2018-05-15 | Alemtuzumab cond (RI ALLO CAMP100) | 02 | null | 220034164 | ALEMTUZUMAB |
| 220017923 | 220009084 | 1.64 | 82.6 | null | 2016-06-17 | 2017-06-12 | Cytarabine intrathecal | N | N | 220034177 | CYTARABINE INTRATHECAL |
| 220017924 | 220009085 | 1.67 | null | Palliative (P) | 2016-09-28 | 2016-09-28 | Cytarabine intrathecal | N | N | 220034194 | CYTARABINE INTRATHECAL |
| 220017925 | 220009087 | null | 82.1 | Curative (C) | 2015-10-04 | 2015-10-19 | ALEMTUZUMAB + BUSULFAN + FLUDARABINE | N | N | 220034195 | FBC |
| 220017926 | 220009089 | 1.83 | 94.2 | Curative (C) | 2015-03-19 | 2015-04-16 | PONATINIB | N | N | 220034214 | CISPLATIN + GEMCITABINE |
| 220017927 | 220009090 | 1.55 | 58.2 | null | 2016-06-20 | 2016-09-27 | Mitox + Tretinoin Spanish Course 3 | 2 | N | 220034218 | MITOXANTRONE |
| 220017930 | 220009099 | null | 63 | null | 2014-09-22 | 2014-09-30 | Clofarabine + Cytarabine | N | null | 220034259 | PONATINIB |
| 220017931 | 220009100 | 1.78 | 64.3 | Palliative (P) | 2014-09-14 | 2014-11-14 | IDARUBICIN | N | N | 220034265 | IDARUBICIN |